Cedars-Sinai to Train Next Generation of Stem Cell Scientists Cedars-Sinai Skip to content Close Select your preferred language English عربى 简体中文 繁體中文 فارسي עִברִית 日本語 한국어 Русский Español Tagalog English English عربى 简体中文 繁體中文 فارسي עִברִית 日本語 한국어 Русский Español Tagalog Translation is unavailable for Internet Explorer Cedars-Sinai Home 1-800-CEDARS-1 1-800-CEDARS-1 Close Find a Doctor Locations Programs & Services Health Library Patient & Visitors Community My CS-Link RESEARCH clear Go Close Navigation Links Academics Faculty Development Community Engagement Calendar Research Research Areas Research Labs Departments & Institutes Find Clinical Trials Research Cores Research Administration Basic Science Research Clinical & Translational Research Center (CTRC) Technology & Innovations News & Breakthroughs Education Graduate Medical Education Continuing Medical Education Graduate School of Biomedical Sciences Professional Training Programs Medical Students Campus Life Office of the Dean Simulation Center Medical Library Program in the History of Medicine About Us All Education Programs Departments & Institutes Faculty Directory Research Back to Research ProtocolCare Basic Science Research Research Cores and Services Proteomic & Metabolomic Research Instrumentation Bioinformatics Service Request Form Bioinformatics Shared Resource User Information Instrumentation Core Services Meet the Team Biostatistics & Bioinformatics Core New User Information Services and Prices Instrumentation Meet the Team Flow Cytometry Core New User Information Instrumentation Services and Prices Scheduling Protocols Ordering Supplies Meet the Team Our Policies Applied Genomics, Computation & Translational Core User Information Instrumentation Services and Prices Meet the Team Publications Links Imaging Core User Information Instrumentation Services and Prices Scheduling Software and Data Tools Facility Access Meet the Team Funding Opportunities Frequently Asked Questions Publications Mitochondria, Metabolism and Cardiac Phenotyping Core User Information Instrumentation Services and Prices Scheduling Ordering Supplies Facility Access Meet the Team Molecular Therapeutics Core Instrumentation Services and Prices FAQs Research Informatics and Scientific Computing Core User Information Services Technologies/Resources Meet the Team Rodent Genetics Core New User Information Instrumentation Services and Prices Scheduling Meet the Team FAQs Imaging Mass Cytometry Core Meet the Team Protocols Instrumentation Vendor List Publications FAQs Data Science Navigator Meet the Team Departments and Institutes Anesthesiology Biomedical Sciences Cardiac Surgery Cardiology Imaging Medicine Neurology Neurosurgery Obstetrics and Gynecology Orthopaedics Pathology & Laboratory Medicine Pediatrics Physical Medicine & Rehabilitation Psychiatry & Behavioral Neurosciences Radiation Oncology Surgery Cancer Institute About Us Membership Privileges & Responsibilities NCI Approved Funding Current Members Apply & Renew Research Programs Cancer Biology Program Expert Team Cancer Prevention & Control Program Team Determinants of Liver Metastasis Program Experimental Therapeutics Program Our Team Send Us a Message Research Education & Training Disease Research Groups Breast Oncology Team Urologic Oncology Team NIH/NCI Program Project Cancer Clinical Trials Office About Clinical Trials OnCore & Clinical Trial Informatics Committees Community Outreach & Engagement Cancer Research Center for Health Equity News & Patient Stories Kao Institute for Autoimmune Diseases and Scleroderma Program Department of Computational Biomedicine Research Labs Al-Louzi Lab Lab Members Publications Anastassiou Lab Research Areas Publications Chute Lab Lab Members Publications Research Areas Silm Lab Lab Members Vujkovic-Cvijin Lab Lab Members Casero Lab Lab Members Research Areas Publications Chen Lab Lab Members Publications Research Areas Crother Lab Lab Members Publications Research Areas Ebinger Lab Lab Members Publications Research Areas Erbay Laboratory Lab Members Publications Research Areas Fert-Bober Lab Lab Members Publications Research Areas Gulati Lab Lab Members Personal Statement Publications Research Areas Knott Lab Lab Members Publications Research Areas Parker Laboratory Lab Members Publications Saghizadeh Ghiam Lab Lab Members Personal Statement Publications Research Areas Sareen Lab Lab Members Personal Statement Publications Research Areas Seki Lab Lab Members Personal Statement Publications Research Areas Shah Lab Lab Members Reagents and Resources Personal Statement Publications Research Areas Sheyn Lab Personal Statement Research Areas Lab Members Publications Shimada Lab Lab Members Publications Research Areas Slomka Lab Lab Members Personal Statement Research Areas Achievements Stripp Lab Lab Members Publications Research Areas Sutterwala & Cassel Lab Lab Members Publications Research Areas Svendsen Lab Lab Members Publications Research Areas Theodorescu Lab Lab Members Personal Statement Publications Research Areas Turkson Lab Salvy Lab Lab Members Sun Lab Lab Members Publications Lahiri Lab Lab Members Publications Research Areas Wolf Lab Lab Members Personal Statement Research Areas Publications Gibb Lab Lab Members Personal Statement Research Areas Publications Heung Lab Lab Members Publications Ibrahim Lab Lab Members Publications Research Areas Yang Lab Lab Members Gonzalez-Hernandez Lab Lab Members Research Areas Publications News Send Us a Message Electronic Research Notebook Cedars-Sinai to Train Next Generation of Stem Cell Scientists Cedars-Sinai is establishing an ambitious program to train the next generation of stem cell scientists, commencing with a $5 million grant from the California Institute for Regenerative Medicine (CIRM). The five-year training grant will allow Cedars-Sinai to develop a diverse group of postdoctoral fellows and early-career physician-scientists, giving them the opportunity to train in highly collaborative laboratories that are pushing the frontiers of stem cell science. "This new award from CIRM highlights Cedars-Sinai's commitment to delivering a creative and collaborative learning environment for the development and growth of all researchers who are interested in regenerative medicine," said Clive Svendsen, PhD, executive director of the Cedars-Sinai Board of Governors Regenerative Medicine Institute and professor of Biomedical Sciences and Medicine. “We are confident that this program will continue to aid in the progression and development of more effective treatments for hard-to-treat diseases.” Clive N. Svendsen, PhD By the end of the program, the group of future leaders will be well-equipped with the skills necessary to develop independent and productive academic careers. “Regenerative medicine is a cutting-edge field with diverse technology and tools to master,” said Wafa Tawackoli, PhD, program director of Education and Training in the Cedars-Sinai Regenerative Medicine Institute. “This grant from CIRM will allow us to continue training successful scientists at Cedars-Sinai.” Under Svendsen's direction, Cedars-Sinai has received 26 awards from CIRM totaling nearly $90 million to help generate new stem cell therapies to treat amyotrophic lateral sclerosis (ALS), advanced coronary artery disease and pulmonary arterial hypertension, among other diseases. Wafa Tawackoli, PhD The newest training grant comes just months after Cedars-Sinai scientists received nearly $12 million from CIRM to launch a clinical trial testing a potential gene and stem cell therapy for ALS, a progressive neurodegenerative disease that damages motor neurons in the brain and spinal cord that control voluntary muscle movement. This award builds on earlier support from the stem cell agency that enabled Cedars-Sinai to investigate the use of stem cells delivered to the spinal cord to treat ALS patients. In late 2019, Cedars-Sinai also received $10.5 million from CIRM to launch a clinical trial to test the safety of using stem cell technology as a potential treatment for retinitis pigmentosa, an inherited eye disease with no known cure. The preclinical research that led to FDA approval of the trial also was funded by a $4.9 million CIRM grant. Research leaders at Cedars-Sinai said they are thrilled to initiate the new training program as they look to push the boundaries of medical and scientific knowledge. "We are extremely grateful for the ongoing support from the California Institute for Regenerative Medicine," said Jeffrey Golden, MD, vice dean of Research and Graduate Education and director of the Burns and Allen Research Institute at Cedars-Sinai. “We are excited to provide the newest trainees with an outstanding team of world-class stem cell scientists and clinicians from across the spectrum of specialties who are at the forefront in advancing scientific discoveries.” To learn more about the new training program, visit the Regenerative Medicine Institute website. Please ensure Javascript is enabled for purposes of website accessibility